Asahi Kasei

Mini-tablets (MTs) contain a small amount of active pharmaceutical ingredients in one small tablet. MTs are advantageous because they can...

Hydrochlorothiazide (HCTZ)/losartan potassium (LOS-K) was used as a model drug to prepare compound tablets through the investigation of the compression...

A significant proportion of pharmaceuticals are now considered multiparticulate systems. Modified-release drug delivery formulations can be designed with engineering precision,...

Systemic rheumatoid arthritis treatment has been associated with numerous side effects. We attempted to formulate hyaluronic acid (HA)-coated teriflunomide (TER)-loaded nanostructured lipid carriers (NLCs) that can...

Limited research has been performed on the downstream processing of nano-co-crystal suspensions into solid oral dosage forms. The objectives of...

A novel approach for preparing drug-containing particles (DCPs) with controlled size distribution and high drug loading was developed using melt...

OBJECTIVE CEOLUSTM UF-711 is highly compactible and flowing microcrystalline cellulose (MCC). While UF-711 has over 1.5 times the compactibility of...

Assessment and understanding of changes in particle size of active pharmaceutical ingredients (API) and excipients as a function of solid...

Developing a robust roller compaction process can be challenging, due to the diversity in process parameters and material properties of...

AsahiKASEI is pleased to announce the launch of our brand new website! We provide an easy way to learn about...